| Name |
Naxil 200 mg šumeće tablete |
| Marketing Authorisation Number |
HR-H-153066441 |
| Active Substance |
acetilcistein |
| Composition |
svaka šumeća tableta sadrži 200 mg acetilcisteina |
| Pharmaceutical Form |
šumeća tableta |
| Manufacturer |
Belupo lijekovi i kozmetika d.d., Koprivnica, Hrvatska |
| Marketing Authorisation Holder |
Belupo lijekovi i kozmetika d.d., Ulica Danica 5, Koprivnica, Hrvatska |
| Marketing Authorisation Date |
26.05.2023 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/23-02/42 |
| Registration Number |
381-12-01/70-23-03 |
| Prescription |
Medicinal product not subject to medical prescription |
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
allowed |
| ATC Code |
R05CB01 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |
